114 related articles for article (PubMed ID: 38394401)
1. Incidence of Coronavirus-2 in cerebrospinal fluid in pregnant Coronavirus Disease 2019 (COVID-19) patients with neurological symptoms.
Akdeniz S; Taskin MH; Oruc MA; Caliskan CS; Celik S
Indian J Pathol Microbiol; 2023 Nov; ():. PubMed ID: 38394401
[TBL] [Abstract][Full Text] [Related]
2. Sinonasal manifestations and dynamic profile of RT-PCR results for SARS-CoV-2 in COVID-19 patients.
Jia X; Shao S; Ren H; Xu Y; Zhao J; Zhao Y; Wang Y; Bao S; Yan J; Wang X; Zhang L
Ann Palliat Med; 2021 Apr; 10(4):4174-4183. PubMed ID: 33832289
[TBL] [Abstract][Full Text] [Related]
3. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
5. The Characteristics of Ocular Findings and the Presence of SARS-CoV-2 in the Tears of Coronavirus Disease 2019 Patients.
Singh K; Pattebahadur R; Shete V; Bang P; Mishra M; Gade N
Cureus; 2023 Sep; 15(9):e44589. PubMed ID: 37795067
[TBL] [Abstract][Full Text] [Related]
6. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.
Ermis U; Rust MI; Bungenberg J; Costa A; Dreher M; Balfanz P; Marx G; Wiesmann M; Reetz K; Tauber SC; Schulz JB
Neurol Res Pract; 2021 Mar; 3(1):17. PubMed ID: 33712089
[TBL] [Abstract][Full Text] [Related]
7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.
Savirón-Cornudella R; Villalba A; Zapardiel J; Andeyro-Garcia M; Esteban LM; Pérez-López FR
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():400-404. PubMed ID: 33285496
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.
Edlow AG; Li JZ; Collier AY; Atyeo C; James KE; Boatin AA; Gray KJ; Bordt EA; Shook LL; Yonker LM; Fasano A; Diouf K; Croul N; Devane S; Yockey LJ; Lima R; Shui J; Matute JD; Lerou PH; Akinwunmi BO; Schmidt A; Feldman J; Hauser BM; Caradonna TM; De la Flor D; D'Avino P; Regan J; Corry H; Coxen K; Fajnzylber J; Pepin D; Seaman MS; Barouch DH; Walker BD; Yu XG; Kaimal AJ; Roberts DJ; Alter G
JAMA Netw Open; 2020 Dec; 3(12):e2030455. PubMed ID: 33351086
[TBL] [Abstract][Full Text] [Related]
10. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors in COVID-19 Patients With New Neurological Manifestations: A Retrospective Cohort Study in a Romanian Neurology Department.
Davidescu EI; Odajiu I; Tulbǎ D; Sandu CD; Bunea T; Sandu G; Mureşanu DF; Bǎlǎnescu P; Popescu BO
Front Aging Neurosci; 2021; 13():645611. PubMed ID: 34220483
[No Abstract] [Full Text] [Related]
12. Association of Nirmatrelvir/Ritonavir Treatment on Upper Respiratory Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcription-Polymerase Chain Reaction (SARS-Cov-2 RT-PCR) Negative Conversion Rates Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19).
Li H; Gao M; You H; Zhang P; Pan Y; Li N; Qin L; Wang H; Li D; Li Y; Qiao H; Gu L; Xu S; Guo W; Wang N; Liu C; Gao P; Niu J; Cao J; Zheng Y
Clin Infect Dis; 2023 Feb; 76(3):e148-e154. PubMed ID: 35870128
[TBL] [Abstract][Full Text] [Related]
13. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
Ling Y; Xu SB; Lin YX; Tian D; Zhu ZQ; Dai FH; Wu F; Song ZG; Huang W; Chen J; Hu BJ; Wang S; Mao EQ; Zhu L; Zhang WH; Lu HZ
Chin Med J (Engl); 2020 May; 133(9):1039-1043. PubMed ID: 32118639
[TBL] [Abstract][Full Text] [Related]
14. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion.
Purja S; Oh S; Kim E
Front Neurol; 2022; 13():887164. PubMed ID: 35911902
[TBL] [Abstract][Full Text] [Related]
16. Colonization of severe acute respiratory syndrome-associated coronavirus among health-care workers screened by nasopharyngeal swab.
Ho HT; Chang MS; Wei TY; Hsieh WS; Hung CC; Yang HM; Lu YT
Chest; 2006 Jan; 129(1):95-101. PubMed ID: 16424418
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid Features in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reverse Transcription Polymerase Chain Reaction (RT-PCR) Positive Patients.
Bellon M; Schweblin C; Lambeng N; Cherpillod P; Vazquez J; Lalive PH; Schibler M; Deffert C
Clin Infect Dis; 2021 Nov; 73(9):e3102-e3105. PubMed ID: 32770235
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2.
Lewis A; Jain R; Frontera J; Placantonakis DG; Galetta S; Balcer L; Melmed KR
J Neuroimaging; 2021 Sep; 31(5):826-848. PubMed ID: 34105198
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
20. A comparative study on the efficiency of commercial reverse transcriptase-Polymerase chain reaction kits for the detection of severe acute respiratory syndrome coronavirus 2 infections.
Ramalingam G; Dhanasezhian A; Murugesan A; Saminathan G; Sivathanu L
Indian J Public Health; 2022; 66(3):276-281. PubMed ID: 36149104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
